About

Heart failure (HF) is a rapidly growing public health issue with an estimated prevalence of >37.7 million individuals globally. HF is a shared chronic phase of cardiac functional impairment secondary to many aetiologies, and patients with HF experience a range of symptoms that affect their quality of life, including dyspnoea, fatigue, poor exercise tolerance and fluid retention.

The burden of HF will continue to rise, due to population aging, population growth and improved treatment of HF and other cardiovascular disorders. As a result, clinicians will be increasingly challenged to develop treatment plans and care systems that reduce the high levels of morbidity and mortality experienced by these patients, both from their HF and other comorbidities.

Articles

Treatment with Impella and Venoarterial Extracorporeal Membrane Oxygenation During Cardiac Arrest Improves Survival: A Multicentre Cohort Study

Published:

28 June 2022

Citation:

Interventional Cardiology Review 2022;17(Suppl 1):17–8.

Keynote Lecture: Treatment of Stage D Heart Failure – Devices, Drugs, Biology and Genes: Evidence and Guidelines

Published:

28 June 2022

Citation:

Interventional Cardiology Review 2022;17(Suppl 1):15–7.

Innovation Lecture: Current Understanding of the Molecular Mechanisms of Unloading and Recovery – Past, Present and Future

Published:

28 June 2022

Citation:

Interventional Cardiology Review 2022;17(Suppl 1):13–5.

Negative Effects of Acute Reloading after Mechanical Left Ventricular Unloading for Acute MI in a Pig Model

Published:

28 June 2022

Citation:

Interventional Cardiology Review 2022;17(Suppl 1):12.